These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma. Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163 [TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma. Aboumohamed AA; Krane LS; Hemal AK J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256 [TBL] [Abstract][Full Text] [Related]
5. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892 [TBL] [Abstract][Full Text] [Related]
6. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors. Akao J; Matsuyama H; Yamamoto Y; Sasaki K; Naito K Clin Cancer Res; 2006 Dec; 12(23):7004-8. PubMed ID: 17145821 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma. Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378 [TBL] [Abstract][Full Text] [Related]
10. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma. Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942 [TBL] [Abstract][Full Text] [Related]
12. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Yamamoto Y; Matsuyama H; Chochi Y; Okuda M; Kawauchi S; Inoue R; Furuya T; Oga A; Naito K; Sasaki K Cancer Genet Cytogenet; 2007 Apr; 174(1):42-7. PubMed ID: 17350465 [TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study. Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093 [TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy. Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens]. Wang Y; He HY Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608 [No Abstract] [Full Text] [Related]
17. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy. Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700 [TBL] [Abstract][Full Text] [Related]
18. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349 [TBL] [Abstract][Full Text] [Related]
20. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M; BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]